Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moritz Jesinghaus

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Nature Metabolism|September 1, 2025
ATF6 activation alters colonic lipid metabolism causing tumour-associated microbial adaptationOlivia I Coleman, Adam Sorbie, Alessandra Riva, et al.
Nature Communications|September 11, 2020
MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeuticallyEnkhtsetseg Munkhbaatar, Michelle Dietzen, Deepti Agrawal, et al.
Cancer Cell|June 23, 2023
An integrated cellular and molecular model of gastric neuroendocrine cancer evolution highlights therapeutic targetsJoscha Griger, Sebastian A Widholz, Moritz Jesinghaus, et al.
Nature Cancer|February 5, 2022
Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironmentChiara Falcomatà, Stefanie Bärthel, Sebastian A Widholz, et al.
Cancer Genetics|April 8, 2026
Optimized precision oncology through implementation of a comprehensive molecular analysis pipeline - relevance for additional therapeutic optionsNuwar Harb, Marcel Romey, Albert Grass, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Nature Metabolism|September 1, 2025
ATF6 activation alters colonic lipid metabolism causing tumour-associated microbial adaptationOlivia I Coleman, Adam Sorbie, Alessandra Riva, et al.
Nature Communications|September 11, 2020
MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeuticallyEnkhtsetseg Munkhbaatar, Michelle Dietzen, Deepti Agrawal, et al.
Cancer Cell|June 23, 2023
An integrated cellular and molecular model of gastric neuroendocrine cancer evolution highlights therapeutic targetsJoscha Griger, Sebastian A Widholz, Moritz Jesinghaus, et al.
Nature Cancer|February 5, 2022
Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironmentChiara Falcomatà, Stefanie Bärthel, Sebastian A Widholz, et al.
Cancer Genetics|April 8, 2026
Optimized precision oncology through implementation of a comprehensive molecular analysis pipeline - relevance for additional therapeutic optionsNuwar Harb, Marcel Romey, Albert Grass, et al.
Pageof 12